These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

453 related articles for article (PubMed ID: 25057985)

  • 21. Pediatric residents' perceived barriers to opioid use in sickle cell disease pain management.
    Fearon A; Marsh A; Kim J; Treadwell M
    Pediatr Blood Cancer; 2019 Feb; 66(2):e27535. PubMed ID: 30387290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reasons for under-use of prescribed opioid medications by patients in pain.
    Lewis ET; Combs A; Trafton JA
    Pain Med; 2010 Jun; 11(6):861-71. PubMed ID: 20624241
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Primary Care Providers' Comfort Levels in Caring for Patients with Sickle Cell Disease.
    Whiteman LN; Haywood C; Lanzkron S; Strouse JJ; Feldman L; Stewart RW
    South Med J; 2015 Sep; 108(9):531-6. PubMed ID: 26332477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sources of Distress in Primary Care Opioid Management and the Role of a Controlled Substance Review Group: A Qualitative Study.
    Hulen E; Saha S; Morasco BJ; Zeigler C; Mackey K; Edwards ST
    Pain Med; 2018 Aug; 19(8):1570-1577. PubMed ID: 29099982
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of the acute painful crisis in sickle cell disease- a re-evaluation of the use of opioids in adult patients.
    Telfer P; Bahal N; Lo A; Challands J
    Br J Haematol; 2014 Jul; 166(2):157-64. PubMed ID: 24750050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Morphine for the treatment of pain in sickle cell disease.
    Gupta M; Msambichaka L; Ballas SK; Gupta K
    ScientificWorldJournal; 2015; 2015():540154. PubMed ID: 25654130
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Understanding the causes of problematic pain management in sickle cell disease: evidence that pseudoaddiction plays a more important role than genuine analgesic dependence.
    Elander J; Lusher J; Bevan D; Telfer P; Burton B
    J Pain Symptom Manage; 2004 Feb; 27(2):156-69. PubMed ID: 15157040
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nurses' attitudes and practices in sickle cell pain management.
    Pack-Mabien A; Labbe E; Herbert D; Haynes J
    Appl Nurs Res; 2001 Nov; 14(4):187-92. PubMed ID: 11699021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sickle cell disease in adults: developing an appropriate care plan.
    Matthie N; Jenerette C
    Clin J Oncol Nurs; 2015 Oct; 19(5):562-7. PubMed ID: 26688919
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adolescents with sickle cell disease in a rural community: are they ready to transition to adulthood?
    Mennito S; Hletko P; Ebeling M; Amann LA; Roberts J
    South Med J; 2014 Sep; 107(9):578-82. PubMed ID: 25188623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Navigating Ethical Challenges for Pediatric Sickle Cell Pain Management in the Context of the Opioid Epidemic.
    Mulchan SS; Wakefield EO; Martin SR; Ayr-Volta L; Krenicki K; Zempsky WT
    Clin J Pain; 2021 Nov; 38(2):88-94. PubMed ID: 34803155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pain in sickle cell disease: current and potential translational therapies.
    Sagi V; Mittal A; Tran H; Gupta K
    Transl Res; 2021 Aug; 234():141-158. PubMed ID: 33711512
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 10-year follow-up of chronic non-malignant pain patients: opioid use, health related quality of life and health care utilization.
    Jensen MK; Thomsen AB; Højsted J
    Eur J Pain; 2006 Jul; 10(5):423-33. PubMed ID: 16054407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pain management in sickle cell disease.
    Jacob E;
    Pain Manag Nurs; 2001 Dec; 2(4):121-31. PubMed ID: 11748547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinician impression versus prescription drug monitoring program criteria in the assessment of drug-seeking behavior in the emergency department.
    Weiner SG; Griggs CA; Mitchell PM; Langlois BK; Friedman FD; Moore RL; Lin SC; Nelson KP; Feldman JA
    Ann Emerg Med; 2013 Oct; 62(4):281-9. PubMed ID: 23849618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sickle cell disease pain management and the medical home.
    Raphael JL; Oyeku SO
    Hematology Am Soc Hematol Educ Program; 2013; 2013():433-8. PubMed ID: 24319216
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Opioid treatment for acute and chronic pain in patients with sickle cell disease.
    Carroll CP
    Neurosci Lett; 2020 Jan; 714():134534. PubMed ID: 31593753
    [TBL] [Abstract][Full Text] [Related]  

  • 38. State of the Art Management of Acute Vaso-occlusive Pain in Sickle Cell Disease.
    Puri L; Nottage KA; Hankins JS; Anghelescu DL
    Paediatr Drugs; 2018 Feb; 20(1):29-42. PubMed ID: 28853040
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comprehensive assessment of chronic pain management in primary care: a first phase of a quality improvement initiative at a multisite Community Health Center.
    Anderson D; Wang S; Zlateva I
    Qual Prim Care; 2012; 20(6):421-33. PubMed ID: 23540822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Attitudes of health care professionals to opioid prescribing in end-of-life care: a qualitative focus group study.
    Gardiner C; Gott M; Ingleton C; Hughes P; Winslow M; Bennett MI
    J Pain Symptom Manage; 2012 Aug; 44(2):206-14. PubMed ID: 22672918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.